Cross-sectional study of complement C3 as a coronary risk factor among men and women
Open Access
- 21 January 2005
- journal article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 108 (2), 129-135
- https://doi.org/10.1042/cs20040198
Abstract
In the present study, we examined (i) whether C3 (complement C3) was an independent marker of prevalent CHD (coronary heart disease), and (ii) which preferential associations existed between C3 and some cardiovascular risk factors when jointly analysed with CRP (C-reactive protein) and fibrinogen. In a cohort of 756 unselected adults, 39% of whom had the metabolic syndrome, C3 and other risk variables were evaluated in a cross-sectional manner. In a logistic regression model for the likelihood of CHD, a significant OR (odds ratio) of 3.5 [95% CI (confidence intervals), 1.27 and 9.62)] for C3 was obtained after adjustment for smoking status, TC (total cholesterol) and usage of statins. A similar model, also comprising systolic blood pressure, with a cut-off point of ≥1.6 g/l C3 exhibited a 1.9-fold risk (95% CI, 1.01 and 3.58) compared with individuals below the cut-off point. Both analyses displayed an adjusted OR of 1.37 for each S.D. increment in C3. The significant relationship of C3 with a likelihood of CHD also proved to be independent of CRP. In multiple linear regression models, associations were tested for each acute-phase protein with measures of obesity, fasting insulin, triacylglycerols (triglycerides), TC, HDL (high-density lipoprotein)-cholesterol, physical activity, smoking status, diagnosis of metabolic syndrome and family income. When both genders were combined, C3 was independently associated with serum triacylglycerols, waist circumference, BMI (body mass index) and TC. CRP was independently associated with waist circumference, TC, family income (inversely) and physical activity, and fibrinogen with BMI, TC, smoking status and metabolic syndrome. In summary, elevated levels of complement C3 are associated with an increased likelihood of CHD independent of standard risk factors and regardless of the presence of acute coronary events, suggesting that C3 might be actively involved in coronary atherothrombosis. Unlike CRP and fibrinogen, C3 was preferentially associated with waist girth and serum triacylglycerols.Keywords
This publication has 27 references indexed in Scilit:
- Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic statusJournal of Epidemiology and Community Health, 2003
- Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluationAtherosclerosis, 2002
- C-reactive protein and coronary heart disease in Western TurkeyThe American Journal of Cardiology, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Relationship of serum C3 complement with insulin resistance and coronary heart disease—cause, consequence or common antecedent?Published by Oxford University Press (OUP) ,2000
- The acute phase responseImmunology Today, 1994
- The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis.Journal of Clinical Investigation, 1993
- Plasma lipids and their interrelationship in Turkish adults.Journal of Epidemiology and Community Health, 1992
- Quantitative studies of the secretion of complement component C3 by resident, elicited and activated macrophages. Comparison with C2, C4 and lysosomal enzyme releaseEuropean Journal of Immunology, 1982
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957